Damjanovska krstikj, LJubinka
Preferred name
Damjanovska krstikj, LJubinka
Official Name
Damjanovska krstikj, LJubinka
Main Affiliation
Email
ljubinka.damjanovska.krstikj@medf.ukim.edu.mk
20 results
Now showing 1 - 10 of 20
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, A Comparison of Two Radiography Scoring Methods Used by Rheumatologists and Radiologists in Patients with Established Rheumatoid Arthritis(Synergy Publishers, 2015-04-29); ;Jordanovska, ElenaBackground: There are numerous radiographic scoring methods in rheumatoid arthritis (RA). The scoring method Sharp/van der Heijde (SHS) is considered “a gold standard” for the assessment of the disease progression in RA. It is reliable but complex scoring method, which is time consuming and is used by well trained readers. The Simple Erosion Narrowing Score (SENS) was derived from the SHS method as an easier, quicker and reliable method for joint lesions scoring. Aim: The aim of the present work is to use and to evaluate the SENS method, for the first time in Macedonia, in comparison with SHS, and to test the agreement between the readers for the two scoring methods, in a group of patients with established RA. Materials and Methods: Evaluation of the patients included collection of demographic and clinical data, physical examination and calculation of the 28-joint Disease Activity Score (DAS-28). Laboratory tests and bilateral radiographs of the hands, wrists and feet were done in each of the patients. The radiographs were scored in pairs by two independent readers: rheumatologist and experienced radiologist. Results: The study group consisted of 54 RA patients. The mean age of the patients was 54,4 years. The average duration of the disease was 4,74 years with the mean DAS 28 score 5,0. The average radiography scores read by the rheumatologist and radiologist were 43,7 vs. 38,6 for the total SENS and 70 vs. 72 for the total SHS score. The interobserver reliability was calculated by the intraclass correlation coefficient (ICC) which was 0,77 for SENS and 0,88 for the SHS score. The intraobserver reliability was 0,76 vs 0,74 for the rheumatologist and radiologist, respectively. Conclusion: The performances of SENS method were good and the reading was very fast and easy. The agreement between the readers was higher for the more detailed SHS score. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Porphyromonas Gingivalis - A Periodontal Pathogen with Potential Role in Rheumatoid Arthritis and its Association with Anti-CCP and Anti-MCV Antibodies Positivity(Synergy Publishers, 2022-02-23) ;Selimov, Pavel ;Firkova, Elena; ;Delcheva, GinkaStankova, TeodoraBackground: In recent studies, a strong association between rheumatoid arthritis (RA) and chronic periodontal disease (CPD) has been identified, indicating common disease pathogenesis and risk factors. One of them is the presence of the pathogen Porphyromonas gingivalis (PG), which can initiate the process of citrullination, by secreting the enzyme Porphyromonas Peptydil Arginine Deminase (PPAD). The aim of the study is to show the presence of PG in RA patients, and to evaluate the association of the PG presence with anti-citrullinated proteins/peptides (ACPA) positivity i.e. anti CCP and anti MCV positivity. Methods: The study included 80 participants - 30 patients which fulfilled 2010 ACR/EULAR RA classification criteria and 50 controls, which were genetically analyzed for the presence of PG by Chelex®100 method and polymerase chain reaction (PCR) and for the presence of anti CCP and anti MCV autoantibodies with the ELISA method. Results: Twenty out of thirty RA patients (80 %) and 16 out of 50 controls (32%) were positive for PG. (χ 2 = 11.461, p <0.001 for OA and χ2 = 13.91, p <0.001 for HC). Of the PG-positive RA patients, 83% had positive anti-CCP and 79% had positive anti-MCV test. The odds ratios OR of 25 and 19 were statistically significant (p = 0.008 and p =0,014 respectfully). Conclusions: PG was present more frequently in RA patients and there was a statistically significant association with anti CCP and anti MCV antibodies. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Late onset of SLE in males: A misdiagnosed disease(Macedonian Association of Anatomists and Morphologists, 2022); ; Systemic lupus erythematosus (SLE) is an autoimmune disease characterisedby the production of antibodies to components of the cell nucleus in association with a diverse array of clinical manifestations. When the immune system attacks its own tissues, it causes widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels. The primary pathological findings in patients with SLE are those of inflammation, vasculitis, immune complex deposition, and vasculopathy.Late-onset SLE represents a specific subgroup of SLE and is often initially missed leading to a significant delay in diagnosis. Elderly patients frequently present to hospital with nonspecific symptoms such as fatigue, recurrent fever of an unknown cause, weight loss, serositis (pleural and/or pericardial effusions), and acute kidney injury.We are describing a case of late onset SLE in a male patient that has been previously only syptomaticaly treated for the complications of the disease itself, whilst it took a longer period for physicians to thinkof SLE and make further investigations about it, because of the age and sex of the patient. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ANTISYNTHETASE SYNDROME: A RARE AND CHALLENGING DIAGNOSIS – CASE REPORT AND LITERATURE REVIEW(Central Medical Library - Bulgaria, 2022-10); ; ; Antisynthetase syndrome (ASS) is rare idiopathic inflammatory myopathy (IIM) characterized principally by myositis, generally symmetrical arthritis and interstitial lung disease (ILD) in association with serum autoantibodies to aminoacyl-transfer RNA synthetases. More variable features include arthralgia, Raynaud phenomenon, heliotrophic rash, distal esophageal dysmotility and mechanic's hands. In this case report we describe a 46-years old woman who initially presented with arthritis and subtle myositis which delayed the recognition of ASS and contributed for considering the condition as seronegative rheumatoid arthritis for several years. During the next few years, the patient was progressively worsening, with a disability to stand up from a sitting position, gradual onset of exertional dyspnea, difficult-to-control dry cough and thick, hyperkeratotic skin of both hands (mechanic’s hands). This constellation of symptoms was highly suspicious for ASS and additional serological and radiological examinations were done which confirmed the diagnosis. The need for further detailed investigation when an interstitial lung disease overlaps with a known rheumatoid condition is obligatory, as shown in this case. A multidisciplinary evaluation is highly recommended to evaluate the clinical, serological and radiological findings in each patient suspected for ASS in order to establish early diagnosis and timely management. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus, a diagnostic and a management challenge(Bulgarian Rheumatology Society, 2023-08-31) ;Krstevski, Mirko; Thrombotic thrombocytopenic purpura (TTP) is a rare, potentially fatal blood disorder that can be challenging for clinicians to identify in the setting of autoimmune diseases such as systemic lupus erythematosus (SLE). SLE can present with thrombotic microangiopathy (TMA) and differentiation between the two diseases can be quite difficult. In this case report we present a 62-year-old female with a history of SLE who was hospitalized with thrombocytopenia, dysarthria, dizziness, paresthesia and altered mental status. The laboratory results revealed direct Coombs negative hemolytic anemia, severe thrombocytopenia, significant elevation of lactate dehydrogenase, leukocytosis and presence of few schistocytes in the peripheral film. In addition, we also present evidence for circulating anti-ADAMTS13 antibody/ADAMTS13 antigen. Based on clinical, hematological, and biochemical findings, we concluded that it was a case of TTP-like microangiopathy associated with SLE and indicated treatment with methylprednisolone pulses and plasmapheresis. Later on, she developed psychosis and made plasmapheresis difficult to perform. We continued corticosteroids (dose 1mg/kg), RhoGAM, Chloroquine and Azathioprine, obtaining a satisfactory response after one week of treatment. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Дијагностичка вредност на анти-цикличните цитрулирани пептидни антитела кај пациенти со ревматоиден артритис(Македонско лекарско друштво = Macedonian Medical Association, 2007); ;В. Анастасовска ;Б. Зафировска; Н. МаринаThe aim of the study was to determine the diagnostic value, specificity and sensitivity of anti-CCP antibodies (ACPA) as a new test for rheumatoid arthritis, in comparison with IgM RF. A cross-sectional study was carried out to analyze the prevalence of ACPA and IgM RF in the sera of 160 randomly selected patients from the Clinic of Rheumatology: 60 with RA, 50 with connective tissue diseases and other rheumatic diseases (non-RA) and 50 healthy controls (HC). All of the RA patients fulfilled the revised ACR classification criteria. Commercial anti-CCP ELISA kits and IgM RF Latex test were used. As expected, ACPA showed comparable sensitivity (66,8% vs. 68,3%) and higher specificity (98% vs. 87%) than IgM R, at optimal cut off values. The ROC curve was generated for both tests. AUC was greater for ACPA than for igM RF (0,92 vs 0,82). The presence of either ACPA or IgM RF increased the testing sensitivity to 76,6%. There was a positive significant correlation between ACPA and IgM RF, r=0,459, p<0,001. ACPA antibodies are very useful serological markers for the diagnosis of RA, with comparable sensitivity and higher specificity than IgM RF. For early and precise diagnosis of RA, the concomitant use of both tests is necessary . - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Satisfaction Level of Rheumatoid Arthritis Patients Enrolled in the Treatment with Subcutaneous Tocilizumab. Journal of Autoimmune Diseases and Rheumatology(Karachi: Synergy Publishers, 2020) ;Filip Guchev; ;D. Antova ;B. OsmaniM. Nikolovska KotevskaBackground: The introduction of biological-Disease Modifying Agents (bDMARDs) has allowed serious improvement in the treatment of patients with rheumatoid arthritis (RA) by providing a better quality of life (QoL). Such improvements have been shown in patients using subcutaneous form of Tocilizumab SC (TCZ-SC), a humanized monoclonal antibody against IL-6 receptor. Objective: To assess the subcutaneous treatment satisfaction level and to evaluate the epidemiological profile of RA patients treated with TCZ-SC in North Macedonian Patients with RA. Methods: An observational study was conducted at the University Rheumatology Clinic in Skopje between October 1st and December 15th 2018, including 48 patients who have received TCZ-SC. In order to obtain patient’s satisfaction level and to evaluate the epidemiological characteristics of the patients, a standardized questionnaire was developed. Results: The mean age of the patient’s cohort was 50.9 years and 88.5% of the patients were females. More than half of the patients (58%) had high disease activity with mean disease duration of 5.35 years. Eighty three percent of the patients were entitled to receive subcutaneous TCZ because of the insufficient efficacy of previous treatment, All patients enrolled in the treatment with TCZ-SC, reported to be satisfied or very satisfied with the subcutaneous application of TCZ. They were also very satisfied with the previous education and the opportunity to receive the treatment at home. Conclusions: Tocilizumab as an efficient and well tolerated bDMARD is becoming a standard of care in the treatment of patients suffering from RA, offering unprecedented benefits for QoL improvement and satisfying the patients’ needs for modern and effective treatment. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Overlap syndrome in refractory case(Macedonian Association of Anatomists, 2022) ;Filip Gucхev; ; This is a report of the case of a 23 years-old girl with refractory dermatomyositis, complications in her treatment and the unfortunate fatal end. Dermatomyositis can be a notoriously difficult disease to treat, and remission is often elusive or short-lived despite aggressive therapy. In the years after the diagnosis, many aggressive modalities of treatment were tried, including rituximab. The patient had frequent exacerbations of the myositis, needed aggressive therapy and developed many side effects associated with the treatment. Most common of these were infections. After suffering severe stress, she developed fever, was diagnosed with sepsis and despite exhaustive treatment at the intensive care unit she passed away. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Rheumatoid arthritis and the proinflammatory cytokine IL-17(Pensoft Publishers, 2023-02-28) ;Selimov, Pavel ;Karalilova, Rositsa; ;Delcheva, GinkaStankova, TeodoraRheumatoid arthritis (RA) is the most common inflammatory joint disease. Various proinflammatory cytokines are involved in the pathogenesis of this chronic disorder. It is characterized by the presence of autoantibodies, such as rheumatoid factor and antibodies against citrullinated peptides. The present study focuses on investigation of possible association between the proinflammatory cytokine interleukin 17 and anti-CCP, anti-MCV, and anti-CarP antibodies seropositivity in RA patients. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Rituximab in treatment of a patient with granulomatosis with polyangitis - a case report(Македонско лекарско друштво = Macedonian medical association, 2023-01); ;Guchev, Filip ;Antova, Dubravka ;Karadzova Stojanovska, AnzhelikaVidinikj, SonjaANCA-associated vasculitis (AAV) is a necrotizing vasculitis with few or no immune deposits that can affect predominantly small vessels. It can affect vessels in every organ and tissue of the body; the clinical manifestations of the disease are extremely variable. B-cells are of major importance in the disease pathogenesis as precursors of ANCA-producing plasma cells and, possibly, also as antigen-presenting and cytokineproducing cells. Therefore, rituximab, a monoclonal antibody drug causing partial B-cell depletion, has emerged as a powerful option in the treatment of AAV such as granulomatosis with polyangiitis. We present the case of a 25-year-old female diagnosed with granulomatosis with polyangiitis and treated with rituximab and high-dose corticosteroids.
